ClinicalTrials.gg
Not yet recruitingNCT06921005Updated Apr 10, 2025

Can Lower-body Occlusion Influence Sports Recovery?

An interventional study of Exercise in Recovery of Function and Sports, sponsored by University of Maia. Not yet recruiting. Open to male participants aged 17 Years to 23 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-10.

Sponsored by University of Maia · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
17 Years to 23 Years
Sex
Male
01

Study summary

This study ai ms to compare the recovery kinetics of different interventions: i) active recovery; ii) continuous vascular occlusion during active recovery; iii) intermittent vascular occlusion during active recovery; iv) control group.

02

Conditions studied

  • Recovery of Function
  • Sports

Keywords

  • sports
  • recovery
  • blood flow restriction
03

In context

Lead sponsor

University of Maia is the lead sponsor of 21 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 23 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • soccer players
  • elite athletes
  • present in the pitch training sessions

Exclusion criteria

Exclusion Criteria:

  • injured athletes
  • female athletes
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    AR

    Active recovery group

    Other: Exercise

  • Experimental
    AR+ continuous BFR

    Active recovery group with continuous blood flow restriction

    Other: Exercise

  • Experimental
    AR + intermittent BFR

    Actve recovery group with intermittent blood flow restriction

    Other: Exercise

  • Active comparator
    Control group

    Control group

    Other: Exercise

Interventions

  • OtherExercise

    Recovery with vascular occlusion or active recovery in soccer players.

06

What researchers measure

Primary outcomes

  1. countermovement jump height

    countermovement jump height measured using chronojump.

    Time frame: Baseline, post 30 minutes, post 24 hours

  2. squat jump height

    Squat jump height measured using chronojump

    Time frame: Baseline, post 30 minutes, post 24 hours

  3. Bar velocity during squat

    Squat velocity measured using a linear encoder

    Time frame: Baseline, post 30 minutes, post 24 hours

  4. hip thrust bar velocity

    hip thrust bar velocity measured using a linear encoder

    Time frame: Baseline, post 30 minutes, post 24 hours

  5. Perceived fatigue

    Perceived fatigue measured using the Rating of Fatigue Scale (range: 0 - 10)

    Time frame: Baseline, post 30 minutes, and post 24 hours.

  6. Muscle soreness Visual Analogue Scale

    Muscle soreness measured using a Visual Analogue Scale (0 - 10)

    Time frame: Baseline, 30 minutes post, 24 hours post.

  7. Perceived recovery

    Perceived recovery measured using the Total Quality Recovery Scale (range 6 - 20)

    Time frame: Baseline, 30 minutes post, 24 hours post.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2025; primary completion for Apr 2025, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2025
First posted
Apr 10, 2025
StartEst.
Apr 10, 2025
Primary completionEst.
Apr 25, 2025
CompletionEst.
Jun 20, 2025
Last update
Apr 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06921005
Lead sponsor
University of Maia
Responsible party
Filipe Silvano Pinto Maia (Principal Investigator, University of Maia) — Principal investigator
First posted
Apr 10, 2025
Start date
Apr 10, 2025 (estimated)
Primary completion
Apr 25, 2025 (estimated)
Completion
Jun 20, 2025 (estimated)
Last update
Apr 10, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion